Rxsight Net Income From Continuing Ops from 2010 to 2024

RXST Stock  USD 46.38  1.55  3.46%   
Rxsight Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2024. From the period from 2010 to 2024, Rxsight Net Loss quarterly data regression had r-value of (0.82) and coefficient of variation of  113.67. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-48.6 M
Current Value
-46.2 M
Quarterly Volatility
81.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
  
Check out the analysis of Rxsight Correlation against competitors.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Latest Rxsight's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Rxsight over the last few years. It is Rxsight's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Rxsight Net Income From Continuing Ops Regression Statistics

Arithmetic Mean71,969,693
Geometric Mean90,016,732
Coefficient Of Variation113.67
Mean Deviation72,333,742
Median126,220,000
Standard Deviation81,811,066
Sample Variance6693.1T
Range193M
R-Value(0.82)
Mean Square Error2324.3T
R-Squared0.68
Significance0.0002
Slope(15,057,851)
Total Sum of Squares93702.7T

Rxsight Net Income From Continuing Ops History

2024-46.2 M
2023-48.6 M
2022-66.8 M
2021-48.7 M
202027.6 M

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-48.6 M-46.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.